February 5: Pharma major Ranbaxy is expected to announce its fourth quarter earnings today. For the quarter ended December 31, the company’s net profit is seen at Rs. 115 crore versus a loss of Rs. 492 crore. This time the Street will actually be watching beyond the basic numbers and focusing more on the management’s commentary in terms of the company’s efforts to resolve U.S. FDA issues. Agam Vakil shares more details on the same.